22157.jpg
Worldwide Gene Therapy Industry to 2028 - Increasing Adoption of Gene Therapy for Oncological Disorders Will Provide Growth Opportunities
15 sept. 2022 07h23 HE | Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
07 sept. 2022 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
06 sept. 2022 16h05 HE | Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and...
Avid Logo June 2022.jpg
Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business
01 sept. 2022 08h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022
30 août 2022 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Global Viral Vectors and Plasmid DNA Manufacturing Market
The Worldwide Viral Vectors and Plasmid DNA Manufacturing Industry is Expected to Reach $2.7 Billion by 2027
25 août 2022 04h58 HE | Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Viral Vectors and Plasmid DNA Manufacturing Market (2022-2027) by Product Type, Application, Geography, Competitive Analysis and the Impact of...
22157.jpg
Global Gene Therapy Market Report 2022: Amid the COVID-19 Crisis, the Market is Projected to Reach a Revised Size of $2.7 Billion by 2026
19 août 2022 05h08 HE | Research and Markets
Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Gene Therapy Market to...
Global Gene Therapy Market
Global Gene Therapy Market 2022-2027: Rising Funding for Gene Therapy Research Boosting Sector
12 août 2022 04h43 HE | Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Gene Therapy Market by Vectors (Non-viral(Oligonucleotides), Viral(Retroviral, Adeno-associated)), Indication (Cancer, Neurological,...
Global Viral Vector & Plasmid DNA Manufacturing Market
Global Viral Vector & Plasmid DNA Manufacturing Market Report to 2027 - Featuring ABL, Biovian and GE Healthcare Among Others
28 juil. 2022 06h13 HE | Research and Markets
Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments
29 juin 2022 16h05 HE | Avid Bioservices, Inc
-- Recorded Fourth Quarter and Full Fiscal Year Revenue of $31 Million and $120 Million, Respectively -- -- Signed $44 Million in Net New Business Orders and Ended the Quarter with a Record High...